1. Home
  2. TRVG vs PRQR Comparison

TRVG vs PRQR Comparison

Compare TRVG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$3.23

Market Cap

197.0M

Sector

Technology

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.44

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
PRQR
Founded
2005
2012
Country
Germany
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
166.5M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
TRVG
PRQR
Price
$3.23
$1.44
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$3.95
$7.25
AVG Volume (30 Days)
77.9K
708.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.59
N/A
Revenue Next Year
$8.42
$13.92
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.33
52 Week High
$5.00
$3.10

Technical Indicators

Market Signals
Indicator
TRVG
PRQR
Relative Strength Index (RSI) 59.10 39.12
Support Level $3.09 $1.36
Resistance Level $3.26 $1.58
Average True Range (ATR) 0.20 0.12
MACD 0.01 -0.02
Stochastic Oscillator 49.45 12.12

Price Performance

Historical Comparison
TRVG
PRQR

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: